What are the complications from CardioMEMS (Cardiovascular Monitoring System) implantation surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Complications of CardioMEMS Implantation Surgery

  • Hemoptysis: a potential life-threatening complication of CardioMEMS sensor implantation, which may be precipitated by a minor wire-induced distal branch pulmonary artery injury 1
  • Device endothelialization: a rare but significant complication that can dampen pressure waveforms, requiring proper placement in vessels larger than 7 mm and careful monitoring of waveforms 2
  • Vascular injury and anesthesia risks: associated with invasive haemodynamic catheterization, which can be avoided with the use of CardioMEMS device 3
  • Dysfunctional implantable pulmonary artery sensor device: requiring reimplantation in some cases 2

Safety and Efficacy of CardioMEMS Implantation

  • No reported complications related to the implantation of the CardioMEMS device in pediatric Fontan patients 3
  • Successful use of the CardioMEMS heart failure system requires an understanding of the technical issues surrounding the implantation procedure 4
  • Alternative access sites, such as brachial vein access, can be used for CardioMEMS implantation in patients who cannot undergo the procedure via routine access sites 5

References

1
Research

Hemoptysis After CardioMEMS Implantation: Case Report and Review.

The American journal of case reports, 2018

5
Research

A Successful CardioMEMS™ Implantation via Brachial Vein Access: A Case Report.

Cardiovascular revascularization medicine : including molecular interventions, 2020

Related Questions

What are the eligibility criteria for CardioMEMS pulmonary‑artery pressure sensor implantation in adult (≥ 18 years) heart‑failure patients with New York Heart Association class III symptoms despite guideline‑directed medical therapy (including an ACE inhibitor or angiotensin‑receptor blocker or angiotensin‑receptor‑neprilysin inhibitor, a beta‑blocker, and a mineralocorticoid‑receptor antagonist unless contraindicated), who have had at least one heart‑failure hospitalization or emergency‑department visit for worsening heart failure in the past 12 months, regardless of left‑ventricular ejection fraction, who have suitable pulmonary‑artery anatomy (mean pulmonary‑artery pressure ≤ 35 mm Hg, no severe pulmonary hypertension, no right‑ventricular outflow obstruction, and no recent pulmonary‑artery interventions), and who have no contraindications such as active systemic infection, uncontrolled coagulopathy, recent major bleeding, end‑stage renal disease requiring dialysis, or inability to perform daily remote transmissions (e.g., severe cognitive impairment, lack of compatible home Wi‑Fi or cellular connection, or inability to operate the handheld device), and who are able and willing to adhere to daily transmission, attend follow‑up visits, and cooperate with the multidisciplinary heart‑failure team?
Is Hepatobiliary Iminodiacetic Acid (HIDA) scan contrast safer than regular Intravenous (IV) contrast?
Is Hepatobiliary Iminodiacetic Acid (HIDA) scan contrast safer than regular Intravenous (IV) contrast?
What is the management of postoperative nausea and vomiting (PONV)?
What is the relationship between Adjustment Disorder and Conduct Disorder?
What type of contrast is given during Magnetic Resonance Cholangiopancreatography (MRCP)?
What type of contrast is given during Magnetic Resonance Cholangiopancreatography (MRCP)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question